Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery

Aouad, Marie T.; Siddik-Sayyid, Sahar M.; Taha, Samar K.; Azar, Mireille; Nasr, Viviane G.; Hakki, M. A.; Zoorob, Dani; Baraka, Anis

doi:10.1017/s0265021506001323

Cited by 51 publications

(30 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In a more recent study, haloperidol 1 mg iv proved to be an effective antiemetic for the early (0-2 hr) prevention of nausea and vomiting. 15 Yet, the overall 24 hr incidence of PONV (41%) did not improve compared with placebo (56% incidence ). In these studies, study medications were administered at the start of anesthesia.…”

Section: Discussionmentioning

confidence: 88%

Haloperidol is as effective as ondansetron for preventing postoperative nausea and vomiting

Lee

Wang

Lai

et al. 2007

Can J Anesth/J Can Anesth

View full text Add to dashboard Cite

Purpose: Recent warnings regarding the safety of droperidol have limited use of this drug as an antiemetic. Haloperidol, a butyrophenone derivative similar to droperidol, has not been rigorously evaluated as an antiemetic. The aim of this study was to compare the prophylactic antiemetic efficacy of haloperidol vs ondansetron for the prevention of postoperative nausea and vomiting (PONV) after general anesthesia.Methods: Ninety non-smoking female patients were eligible to participate in this randomized double-blinded study. Approximately 30 min before the end of surgery, patients were randomly assigned to receive either haloperidol 2 mg iv, or ondansetron 4 mg iv, respectively. The incidence of PONV, average pain and sedation scores, recovery times, and changes of the rate-corrected QT (QTc) interval were observed postoperatively. Results:The proportion of patients who experienced PONV in the first 24 hr was similar in the two groups (28% and 26% for haloperidol and ondansetron groups, respectively). The incidence of PONV was significantly less in both groups than predicted according to the patients' underlying risks (53% for the haloperidol group, P = 0.016; 51% for the ondansetron group, P = 0.015). Pain scores, sedation scores, and recovery times were similar in the two groups, and no prolongation of the QTc interval was observed in either group. Conclusions: Haloperidol 2 mg iv given 30 min before the end of surgery is effective in preventing PONV, with efficacy comparable to ondansetron 4 mg iv for the first 24 hr after general anesthesia.

show abstract

Section: Discussionmentioning

confidence: 88%

Haloperidol is as effective as ondansetron for preventing postoperative nausea and vomiting

Lee

Wang

Lai

et al. 2007

Can J Anesth/J Can Anesth

View full text Add to dashboard Cite

show abstract

“…They concluded that the FDA recommendations for additional 12 lead ECG monitoring after administration of low dose droperidol are unwarranted. Recently, Aouad et al 5 observed that the mean QTc interval was not significantly different after intravenous haloperidol compared to ondansetron and saline. Therefore, we did not perform 12 lead ECGs to evaluate the QT interval.…”

Section: Discussionmentioning

confidence: 98%

“…Prophylactic administration of haloperidol 1 mg proved to be an effective antiemetic for the early (0-2 hr) prevention of nausea and vomiting following gynecological surgery. 5 Yet, the overall 24 hr incidence of PONV (41%) did not improve compared to placebo (56%). In these studies, haloperidol was administered at the start of anesthesia.…”

Section: Conclusion : Le Moment Choisi Pour L'administration De 2 Mg mentioning

confidence: 88%

“…Aouad et al 5 reported that haloperidol 1 mg decreases the incidence and severity of PONV, but only during the early (0-2 hr) postoperative period. Parlow et al 4 showed that haloperidol doses of 1 and 2 mg were effective at reducing intrathecal morphinerelated PONV, particularly during the first 12 hr of follow-up.…”

Section: Discussionmentioning

confidence: 99%

“…Furthermore, haloperidol has been shown previously to have superior antiemetic effects as compared to saline. 4,5,15 Therefore, in lieu of a placebo comparison group, the observed incidences of PONV for both treatment groups were compared to the predicted incidence of PONV before treatment based upon the risk score. The results showed that 30% of Group 1 patients and 26% of Group 2 patients reported PONV within the first 24 hr after haloperidol treatment, which was significantly less than that predicted (60%) according to patients' underlying risks.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

The timing of haloperidol administration does not affect its prophylactic antiemetic efficacy

Yang

Lai

Wang

et al. 2008

Can J Anesth/J Can Anesth

View full text Add to dashboard Cite

Purpose: Postoperative nausea and vomiting (PONV) occurs frequently after general anesthesia. We evaluated the timing of 2 mg iv doses of haloperidol on the efficacy of this drug as a prophylactic antiemetic for PONV. Methods: Ninety-four non-smoking female patients with a history of motion sickness and/or PONV (Apfel's simplified risk score = 3; predicted incidence of PONV = 60%) were eligible to participate in this randomized, double-blind study. Patients were divided into two groups. Group 1 patients received haloperidol 2 mg iv during induction of anesthesia. Group 2 patients received haloperidol 2 mg iv approximately 30 min before the end of surgery. The occurrence of nausea and vomiting, nausea scores, pain scores, sedation levels, and adverse effects (cardiac arrhythmias, and extrapyramidal effects) were recorded by a trained, blinded investigator. Results:The percentages of patients who experienced PONV in the first 24 hr were similar for the two groups (Group 1 = 30%; Group 2 = 26%, P = 0.645). The incidence of PONV was significantly smaller in both groups than that predicted (60%) according to the patients' underlying risks (Group 1, P = 0.004; Group 2, P = 0.001). Nausea scores, pain scores, sedation scores, emergence times, and time to first rescue treatment were similar in the two groups. No adverse effects attributable to the study medication were observed. Conclusion:The timing of administration of haloperidol 2 mg iv does not influence its antiemetic efficacy. The recovery profiles were also similar whether haloperidol was administered at the start, or at the end of surgery. Reports of Original InvestigationsThe timing of haloperidol administration does not affect its prophylactic antiemetic efficacy Address correspondence to: Dr. Yi Lee, Department of Anesthesiology, Buddhist Tzu-Chi Medical Center, Buddhist Tzu-Chi University School of Medicine, No. 707, Section 3, Chung-Yang Road, Hualien, Taiwan, ROC. E-mail: drleeyi2001@yahoo.com.tw There were no direct funding sources (departmental, hospital, institutional, commercial) supporting this work. There are no commercial or non-commercial affiliations that were, or might be perceived to be, a conflict of interest amongst the authors relating to publication of the data. The clinical trial registration number (Buddhist Tzu Chi Medical Center): IRB094-41.

show abstract

Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis

Weibel

Rücker

Eberhart

et al. 2020

Cochrane Database of Systematic Reviews

111

133

View full text Add to dashboard Cite

Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery

Cited by 51 publications

References 32 publications

Haloperidol is as effective as ondansetron for preventing postoperative nausea and vomiting

Haloperidol is as effective as ondansetron for preventing postoperative nausea and vomiting

The timing of haloperidol administration does not affect its prophylactic antiemetic efficacy

Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis

Contact Info

Product

Resources

About